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Preface I do not recall the exact date, but I clearly remember how excited we were to find an 'illuminated' liver tumor in the OR one day in 2007. It was several weeks later that we started a prospective study on intraoperative ICG fluorescence cholangiography during liver surgery. We injected 100-fold diluted ICG solution via a tube inserted into the cystic duct to obtain anatomical information on the biliary tree. The patient had a recurrent hepatocellular carcinoma (HCC). Following cholecystectomy and insertion of a C-tube, we applied a near-infrared camera for fluorescence cholangiography.
Immediately after the intrabiliary injection of ICG, we could identify the biliary tree, as expected. At the same time, however, we also found that the tumor itself was illuminating! Wait a second, has the tumor not been fluorescing from before the injection of ICG into the cystic duct? Instantly, we realized that the fluorescence of the tumor originated, in all likelihood, not from the ICG that we injected intraoperatively into the cystic duct, but from the ICG that we had injected 1 week before the operation as part of preoperative liver function testing. It was then quite natural for liver surgeons to hypothesize that HCC cells can also take up ICG, just like hepatocytes, from which they arise. Normal hepatocytes quickly excrete ICG into the bile, so that they no longer illuminate fluorescence 1 week after the ICG injection. On the other hand, in the case of HCC cells, possibly on account of the disturbed excretory function of the cells, ICG excretion may be impaired and the ICG may be retained for weeks in the HCC cells. So far, evidence supports this aforementioned hypothesis, and molecular analyses on the genes encoding the transporters of this dye may help in a clearer elucidation of this phenomenon in the near future.
ICG is an old friend for hepatobiliary surgeons. It received FDA approval for clinical use more than half a century ago, and has been a very useful dye for liver function testing. ICG fluorescence angiography was applied first for visualizing the retinal artery by ophthalmologists in the late 1960s. It was then applied to the study of cerebral arteries, coronary arteries, limb arteries, mesenteric arteries, etc. With recent advances in imaging technologies, ICG has received renewed attention in the field of hepatobiliary surgery as a new tool for visualizing the biliary tree and liver tumors. What is unfortunate for this very useful dye in medicine, however, is that it is very cheap
